Cross-border M&A originating from developing countries (The case of the Indian pharmaceutical industry)

Abstract

Purpose

The paper aims to highlight the growing use of M&A as a strategic tool by companies originating from the emerging markets.

Findings

Cross-border mergers play an increasingly important role in the strategies of firms originating from developing countries in expanding their capabilities and expertise within the drug discovery value chain by providing world class service and international business knowledge.

Originality/value

M&A literature is very extensive. However, there is need for more research focusing on M&A activity originating from emerging countries.

Citation

Amir-Aslani, A. and Chanel, M.A. (2016), "Cross-border M&A originating from developing countries (The case of the Indian pharmaceutical industry)", Strategic Direction, Vol. 32 No. 9, pp. 19-21. https://doi.org/10.1108/SD-05-2016-0062